Close
Nordic 9Nordic 9

Valanx (private company)

Austria valanx.bio
See something wrong or missing? Let us know
Offices:Graz
Industry:BiotechHealth services
Business model:B2B

Valanx is a biotech startup in Austria developing a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Valanx

Name Criteria
Germany Adrenomed AG
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Norway APIM Therapeutics
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Sweden Aprea Therapeutics
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Spain AptaTargets
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Spain Arthex Biotech S.L.
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Germany Atai Life Sciences
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
Sweden Athera
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
Sweden AttgeNO
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
United Kingdom Biofidelity
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
Denmark Biograil
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
Top